IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Avidity Biosciences Inc

Q2 2026 vs Q3 2026

Comparing institutional holders between quarters

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Byrne Asset Management LLC
UNCHANGED
Shares102 from 102
Change0 (0%)
Value$830 (-$542)
Filed 2026-10-06
Status
Byrne Asset Management LLC
UNCHANGED10210200%$1.4K$830-$5422026-10-06
Showing 1 of 1 institutions